Frontlight ResearchEarly access
WithdrawnNo phase
A Six-Month Prospective Follow-Up Study of WB001
Key facts
- Who runs it
- Woebot Health
- Trial code
- Status
- Withdrawn
- Started
- 1 Feb 2023
- Ended
- 8 Jun 2024
- Type of study
- Observational
- Treatments tested
- Observational
- Record updated
- 6 May 2023
- Why it stopped
- Internal company decision
Who can take part
- Age
- 22 years to 45 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Must have prior enrollment in the WB001-001 trial and completion of Week 8/EOT
- Must be willing and able to comply with all study procedures
Who cannot take part
- Documented AE or SAE at WB001-001 Week 8 related to participant safety, by Investigator judgement
About the trial
What the trial wants to find out
This study is a 6-month follow-up study to WB001-001 conducted to assess and evaluate the durability of the effect of {WB001+TAU} beyond the 8-week treatment period.
The group in the trial
- Follow-up Group
Participants randomized to {WB001+TAU} and {ED001+TAU} in the parent study (WB001-001) will be assessed for 6 months following treatment completion.
Treatment: Observational
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Six-Month Prospective Follow-Up Study of WB001 in Mild to Moderate Postpartum Depression
- Record updated
- 6 May 2023